Filing Details
Xenetic Biosciences, Inc. (NASDAQ:XBIO) filed a Form 8-K with the Securities and Exchange Commission on August 07, 2026, disclosing a material event.
8k filedNASDAQ:XBIO
Xenetic Biosciences, Inc. (XBIO) Reports Material Event to SEC
Xenetic Biosciences, Inc. (NASDAQ:XBIO) filed a Form 8-K with the Securities and Exchange Commission on August 07, 2026, disclosing a material event.
At publication ·
What changed
Xenetic Biosciences, Inc. (NASDAQ:XBIO) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Xenetic Biosciences, Inc. (NASDAQ: XBIO) filed a Form 8-K with the SEC on August 07, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $3.17 with a market capitalization of $3.8 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Xenetic Biosciences, Inc.'s stock currently trades at $3.17 with a market capitalization of $3.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Xenetic Biosciences, Inc.'s stock.
All SEC filings for Xenetic Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View XBIO Stock Page
Frequently Asked Questions
Where can I read XBIO's SEC filings?
Browse all filings on our XBIO SEC filings page.
What types of SEC filings does Xenetic Biosciences, Inc. file?
Public companies like Xenetic Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.